Bahrain Mumtalakat Holding Company BSC(c), the country’s sovereign wealth fund, has partnered with SandboxAQ, a leading global company in artificial intelligence and quantum technologies, to build a new biotech ecosystem in Bahrain. This collaboration will use SandboxAQ’s AI and modeling skills to find and create new treatments and innovative medicines. The partnership is expected to bring over $1 billion in value through new biotech projects and position Bahrain as a key center for life sciences in the region.
Health Technology Insights: ExaCare AI Raises $30 Million to Transform Nursing Admissions
The project will be led by a joint research group that will manage a three-year plan focused on developing new and commercially useful drugs. This plan will combine Bahrain’s national resources with SandboxAQ’s technology to speed up drug discovery and encourage innovation in healthcare.
Health Technology Insights: Microsoft Expands Dragon Copilot AI for Nurses and Partners
HE Shaikh Abdulla bin Khalifa Al Khalifa, CEO of Mumtalakat, said this partnership is an important step in diversifying Bahrain’s economy and boosting its health industry. He explained that using advanced AI and modeling tools will help Bahrain develop new medicines while promoting economic growth and building a more innovative healthcare system.
Jack Hidary, CEO of SandboxAQ, noted that the collaboration offers a chance to create a biotech economy that focuses on generating intellectual property. He stressed that using AI to improve drug discovery will not only boost research but also attract more investment to the country, supporting long-term growth in the biotech field.
This partnership highlights Bahrain’s goal to combine advanced technology with national resources to build a strong and globally competitive biotech industry. By encouraging innovation and developing new therapies, both companies aim to create economic benefits while improving healthcare options for the region.
Health Technology Insights: INITIO Medical Named First ICPO Theranostics Center in North America
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
